What Factors Are Associated With Implant Revision in the Treatment of Pathologic Subtrochanteric Femur Fractures?

医学 股骨 外科 植入 人口 股骨骨折 累积发病率 病理性骨折 入射(几何) 骨科手术 移植 环境卫生 光学 物理
作者
Christopher R. Leland,Marcos R. Gonzalez,Joseph O. Werenski,Antonino Vallone,Kirsten G. Brighton,Erik T. Newman,Santiago A. Lozano‐Calderón,Kevin A. Raskin
出处
期刊:Clinical Orthopaedics and Related Research [Ovid Technologies (Wolters Kluwer)]
标识
DOI:10.1097/corr.0000000000003291
摘要

Background Limiting reoperation or revision after operative stabilization or endoprosthetic reconstruction of a pathologic subtrochanteric femur fracture reduces morbidity, but how best to achieve this remains controversial. Endoprosthetic reconstruction offers durable mechanical stability but may not be most appropriate in patients who are frail or who are not expected to survive more than a few months. For that reason, cumulative incidence survival (looking at the endpoint of reoperation or revision with death as a competing risk) and factors associated with revision after surgical stabilization or reconstruction—both of which remain poorly characterized to date—would help surgeons make better decisions on behalf of these patients. Questions/purposes We analyzed patients who were operatively treated for pathologic subtrochanteric femur fracture, and we asked: (1) What is the cumulative incidence of reoperation and revision at 3 months, 1 year, and 2 years after surgery for pathologic subtrochanteric femur fracture in patients undergoing each treatment type with death as a competing risk? (2) What are the factors associated with implant revision after operative treatment of pathologic subtrochanteric femur fracture? (3) What is the overall survival of patients in this population after surgery? (4) How do clinical and surgical factors along with the frequency of complications compare in this population by operative treatment? Methods Between January 2000 and December 2020, 422 patients underwent surgery for completed proximal femur pathologic fractures. After excluding patients with non-subtrochanteric femur fractures (71% [301]), fractures caused by primary tumors of bone (< 1% [2]), and insufficient data (1% [6]), we included 113 patients who underwent operative treatment of completed pathologic subtrochanteric femur fractures. Our study period spanned 20 years because although implant trends may have shifted, the overall operative objective for pathologic subtrochanteric femur fractures—restoring function and alleviating pain, regardless of the extent of bony union—have remained relatively unchanged during this period. Median follow-up time was 6 months (range 1 month to 20.6 years). Intramedullary nailing (IMN) was performed in 68% (77) of patients, proximal femur replacement (PFR) was performed in 19% (22), and open reduction and internal fixation (ORIF) was performed in 12% (14) of patients. IMN was performed in patients with a poor prognosis but in whom fracture stabilization was felt to be advantageous. In instances of complex fractures in which adequate reduction could not be achieved, ORIF was generally performed. PFR was generally performed in patients with a better prognosis in which long-term implant survival and patient function were prioritized. We found a higher proportion of women in the IMN group (73% versus 32% in PFR and 50% in ORIF; p = 0.001). Rapid growth tumors (Katagiri classification) were found in 25% of patients with IMN, 27% with PFR, and 43% with ORIF. The primary outcome was the cumulative incidence of reoperation or revision surgery after initial stabilization. Competing risk analysis with death as a competing event was performed to estimate the cumulative incidence for reoperation and revision. Factors associated with revision surgery were identified using the Cox proportional hazards model, which rendered HRs. All analyses were adjusted to control for potential confounders. Results The cumulative incidence for reoperation at 2 years was 5% (95% confidence interval [CI] 4% to 6%) for IMN, 15% (95% CI 9% to 22%) for PFR, and 32% (95% CI 15% to 50%) for ORIF (p = 0.03). The cumulative incidence for revision at 2 years was 4% (95% CI 3% to 4%) for IMN, 4% (95% CI 2% to 6%) for PFR, and 33% (95% CI 15% to 51%) for ORIF (p = 0.01). Factors associated with revision surgery were radioresistant tumor histology (HR 8.5 [95% CI 1.2 to 58.9]; p = 0.03) and ORIF (HR 6.3 [95% CI 1.5 to 27.0]; p = 0.01). The 3-month, 1-year, and 2-year overall survival was 80% (95% CI 71% to 87%), 35% (95% CI 26% to 45%), and 28% (95% CI 19% to 36%), respectively. Thirty-day postoperative complications did not differ by fixation type, but 90-day readmission was highest after ORIF (3 of 14 versus 4 of 22 in PFR and 4% [3 of 77] in IMN; p = 0.03) Periprosthetic joint infection (PJI) was more common after salvage PFR (2 of 6) than primary PFR (1 of 22) (p = 0.04). Conclusion Primary PFR may be preferred for pathologic subtrochanteric femur fractures arising from radioresistant tumor types, as the cumulative incidence of revision was no different than for IMN while restoring function, alleviating pain, and offering local tumor control, and it less commonly develops PJI than salvage PFR. In complex fractures not amenable to IMN, surgeons should consider performing a PFR over ORIF because of the lower risk of revision and the added benefit of replacing the pathologic fracture altogether and offering immediate mechanical stability with a cemented endoprosthesis. Future studies might evaluate the extent of bone loss from local tumor burden, and this could be quantified and analyzed in future studies as a covariate as it may clarify when PFR is advantageous in this population. Level of Evidence Level III, therapeutic study.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
junze完成签到,获得积分10
刚刚
Swan完成签到 ,获得积分10
刚刚
matchais1ife完成签到 ,获得积分10
刚刚
JamesPei应助qaw采纳,获得10
1秒前
learn应助狂野傲薇采纳,获得10
2秒前
2秒前
顺心的筮发布了新的文献求助10
2秒前
JofferyChan完成签到,获得积分10
2秒前
jason发布了新的文献求助10
3秒前
科研通AI2S应助冷静的荔枝采纳,获得10
3秒前
4秒前
4秒前
yongyuyu完成签到,获得积分20
4秒前
planA完成签到,获得积分10
4秒前
5秒前
6秒前
6秒前
6秒前
6秒前
骄阳似我发布了新的文献求助10
7秒前
8秒前
8秒前
罗舒给罗舒的求助进行了留言
8秒前
令狐剑愁发布了新的文献求助10
9秒前
CipherSage应助stark采纳,获得10
9秒前
9秒前
申雪狐发布了新的文献求助10
9秒前
10秒前
科研通AI2S应助李崋壹采纳,获得10
10秒前
sunaijia应助jason采纳,获得10
10秒前
少女徐必成完成签到 ,获得积分10
10秒前
平淡南松发布了新的文献求助10
11秒前
Changlu发布了新的文献求助10
11秒前
11秒前
fwch发布了新的文献求助20
11秒前
重回地球完成签到,获得积分10
11秒前
12秒前
12秒前
今后应助张宇采纳,获得10
12秒前
Bzz发布了新的文献求助10
12秒前
高分求助中
Sustainability in Tides Chemistry 2000
Microlepidoptera Palaearctica, Volumes 1 and 3 - 13 (12-Volume Set) [German] 1122
Дружба 友好报 (1957-1958) 1000
The Data Economy: Tools and Applications 1000
Mantiden - Faszinierende Lauerjäger – Buch gebraucht kaufen 600
PraxisRatgeber Mantiden., faszinierende Lauerjäger. – Buch gebraucht kaufe 600
A Dissection Guide & Atlas to the Rabbit 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3105631
求助须知:如何正确求助?哪些是违规求助? 2756681
关于积分的说明 7641226
捐赠科研通 2410796
什么是DOI,文献DOI怎么找? 1279097
科研通“疑难数据库(出版商)”最低求助积分说明 617641
版权声明 599262